{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:56:49Z","timestamp":1771563409600,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Glaucoma is a leading cause of global blindness, especially preventable blindness. The increased prevalence of glaucoma has led to a growing demand for newer, safer, more rapid, and simpler treatments for the reduction of intraocular pressure (IOP). In this study, we evaluated the safety and feasibility of performing filtration glaucoma surgery with an Ab-Interno Er:YAG laser in rabbits.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Nine New Zealand White rabbits age 16\u2009weeks were studied. After subconjunctival injection of mitomycin C (MMC), a novel Ab-Interno Er:YAG laser probe was inserted into the anterior chamber (AC) through a clear corneal 1\u2009mm paracentesis and directed at the trabecular meshwork adjacent to the MMC injection area. A pulsed laser beam was applied to create a patent sclerostomy connecting the AC to the subconjuctival space, resulting in a filtering bleb. The laser system used was the Er:YAG laser system - LAS25-FCU, (Pantec Biosolutions AG, Liechtenstein). Parameters used: Wave lengh: 2940\u2009nm, Pulse length: 100\u2013400\u2009\u03bcsec,frequency: 250\u2009Hz. Average laser power in accordance to the fiber tip diameter: 0.85\u2009W(range 0.8\u20130.92\u2009W). Complete ocular exams, including IOP measurements, were performed on 1, 7, 14, and 23\u2009days postoperatively. Three rabbits were sacrificed on days 1, 14, and 23, and histological examinations were performed on all nine eyes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All procedures resulted in a functional medium-large superior bleb without significant complications. The bleb was sustained in all rabbits by day 14 and in one of the three rabbits that reached the last follow-up at 23\u2009days. No cases of postoperative hypotony were observed. There was a transient significant reduction in mean IOP on postoperative days 5 and 7 (<jats:italic>P<\/jats:italic>\u2009=\u20090.028). Histopathological analysis revealed a patent full-thickness scleral tunnel with only a minor degree of surrounding coagulation necrosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The Ab-Interno laser sclerostomy procedure is potentially safe and effective based on initial experience in an in-vivo rabbit animal model.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-021-01986-4","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T16:03:04Z","timestamp":1621526584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Er:YAG laser-assisted filtration surgery: initial results in rabbits"],"prefix":"10.1186","volume":"21","author":[{"given":"Noa","family":"Kapelushnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"Leshno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reut","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Huna-Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaniv","family":"Barkana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alon","family":"Skaat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"issue":"5","key":"1986_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/bjo.80.5.389","volume":"80","author":"HA Quigley","year":"1996","unstructured":"Quigley HA. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 1996;80(5):389\u201393. https:\/\/doi.org\/10.1136\/bjo.80.5.389.","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"1986_CR2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Y-C Tham","year":"2014","unstructured":"Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology. 2014;121(11):2081\u201390. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013.","journal-title":"Ophthalmology."},{"key":"1986_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/bs.pbr.2015.04.007","volume":"221","author":"D Blumberg","year":"2015","unstructured":"Blumberg D, Skaat A, Liebmann JM. Emerging risk factors for glaucoma onset and progression. Prog Brain Res. 2015;221:81\u2013101. https:\/\/doi.org\/10.1016\/bs.pbr.2015.04.007.","journal-title":"Prog Brain Res"},{"issue":"4","key":"1986_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","volume":"130","author":"DE Gaasterland","year":"2000","unstructured":"Gaasterland DE, Ederer F, Beck A, et al. The advanced Glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130(4):429\u201340. https:\/\/doi.org\/10.1016\/S0002-9394(00)00538-9.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"1986_CR5","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the early manifest Glaucoma trial. Arch Ophthalmol. 2002;120(10):1268\u201379. https:\/\/doi.org\/10.1001\/archopht.120.10.1268.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"1986_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/IIO.0000000000000231","volume":"58","author":"KJ Koike","year":"2018","unstructured":"Koike KJ, Chang PT. Trabeculectomy. Int Ophthalmol Clin. 2018;58(3):117\u201333. https:\/\/doi.org\/10.1097\/IIO.0000000000000231.","journal-title":"Int Ophthalmol Clin"},{"issue":"4","key":"1986_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/0002-9394(68)91288-9","volume":"66","author":"JE Cairns","year":"1968","unstructured":"Cairns JE. Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol. 1968;66(4):673\u20139. https:\/\/doi.org\/10.1016\/0002-9394(68)91288-9.","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"1986_CR8","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.4103\/ijo.IJO_555_18","volume":"66","author":"H Kumar","year":"2018","unstructured":"Kumar H, Mansoori T, Warjri G, Somarajan B, Bandil S, Gupta V. Lasers in glaucoma. Indian J Ophthalmol. 2018;66(11):1539\u201353. https:\/\/doi.org\/10.4103\/ijo.IJO_555_18.","journal-title":"Indian J Ophthalmol"},{"issue":"01","key":"1986_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.17925\/eor.2012.06.01.12","volume":"06","author":"N Geffen","year":"2012","unstructured":"Geffen N, Ton Y, Mu\u00f1oz G, Mariotti C, Assia EI. CO2 laser-assisted sclerectomy surgery for open-angle glaucoma. Eur Ophthalmic Rev. 2012;06(01):12. https:\/\/doi.org\/10.17925\/eor.2012.06.01.12.","journal-title":"Eur Ophthalmic Rev"},{"issue":"5","key":"1986_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/lsm.1900130511","volume":"13","author":"RA Hill","year":"1993","unstructured":"Hill RA, Le MT, Yashiro H, et al. Ab-interno erbium (Er):YAG laser sclerostomy with iridotomy in Dutch cross rabbits. Lasers Surg Med. 1993;13(5):559\u201364. https:\/\/doi.org\/10.1002\/lsm.1900130511.","journal-title":"Lasers Surg Med"},{"issue":"4","key":"1986_CR11","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0002-9394(14)70173-4","volume":"123","author":"PC Jacobi","year":"1997","unstructured":"Jacobi PC, Dietlein TS, Krieglstein GK. Prospective study of Ab externo erbium: YAG laser sclerostomy in humans. Am J Ophthalmol. 1997;123(4):478\u201386. https:\/\/doi.org\/10.1016\/S0002-9394(14)70173-4.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"1986_CR12","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/S0161-6420(93)31538-1","volume":"100","author":"JS Schuman","year":"1993","unstructured":"Schuman JS, Stinson WG, Hutchinson BT, Bellows AR, Puliafito CA, Lytle R. Holmium laser sclerectomy: success and complications. Ophthalmology. 1993;100(7):1060\u20135. https:\/\/doi.org\/10.1016\/S0161-6420(93)31538-1.","journal-title":"Ophthalmology."},{"issue":"2","key":"1986_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1006\/exer.1996.0274","volume":"65","author":"ML McHam","year":"1997","unstructured":"McHam ML, Eisenberg DL, Schuman JS, Wang N. Erbium: YAG laser trabecular ablation with a sapphire optical fiber. Exp Eye Res. 1997;65(2):151\u20135. https:\/\/doi.org\/10.1006\/exer.1996.0274.","journal-title":"Exp Eye Res"},{"issue":"3","key":"1986_CR14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3928\/1542-8877-20020501-08","volume":"33","author":"A Mizota","year":"2002","unstructured":"Mizota A, Takasoh M, Kobayashi K, Parel JM, Manns F, Rol P. Internal sclerostomy with the Er:YAG laser using a gradient-index (GRIN) endoscope. Ophthalmic Surg Lasers. 2002;33(3):214\u201320. https:\/\/doi.org\/10.3928\/1542-8877-20020501-08.","journal-title":"Ophthalmic Surg Lasers"},{"issue":"7","key":"1986_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/s0021-5155(00)00322-1","volume":"104","author":"A Mizota","year":"2000","unstructured":"Mizota A, Takasoh M, Tsuyama Y, Kobayashi K, Momiuchi M. Sclerostomy with an erbium YAG laser -the relationship with pulse energy. J Japanese Ophthalmol Soc. 2000;104(7):453\u20137. https:\/\/doi.org\/10.1016\/s0021-5155(00)00322-1.","journal-title":"J Japanese Ophthalmol Soc"},{"issue":"2","key":"1986_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/0192623315623265","volume":"44","author":"R Kerlin","year":"2016","unstructured":"Kerlin R, Bolon B, Burkhardt J, Francke S, Greaves P, Meador V, et al. Scientific and regulatory policy committee: recommended (\u201cbest\u201d) practices for determining, communicating, and using adverse effect data from nonclinical studies. Toxicol Pathol. 2016;44(2):147\u201362. https:\/\/doi.org\/10.1177\/0192623315623265.","journal-title":"Toxicol Pathol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-01986-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-021-01986-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-01986-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T16:04:15Z","timestamp":1621526655000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-01986-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1986"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-01986-4","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,20]]},"assertion":[{"value":"10 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for this study was obtained by the Israel national ethics committee for experiments in animals. It adhered to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and was carried out in compliance with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"226"}}